SUNPHARMA

### Stocks in Focus **

** – Sun Pharmaceutical Industries has announced the acquisition of **100% stake in Innovcare Lifesciences** for approximately **₹271 crore**. The acquisition is expected to strengthen Sun Pharma’s domestic formulations portfolio and expand its presence in key therapeutic segments. *(Positive)* ** !LT ** – 's AI venture ******* has launched a dedicated **AI Computing Infrastructure Division**, marking a strategic step to capitalize on growing demand for artificial intelligence, high-performance computing, and enterprise AI solutions. *(Positive)* ### Other Stocks Drawing Attention ** ** – In focus amid continued interest in industrial and capital goods stocks. ** ** – Remains under watch due to developments around refinancing plans and critical minerals initiatives. ** ** – Investors are tracking business growth momentum and corporate developments. ** ** – Continues to attract attention amid infrastructure and engineering sector opportunities. ** ** – Defence and manufacturing themes remain supportive, with investors monitoringg order inflows and export opportunities. ### Market Impact ** :** Acquisition strengthens domestic business and supports long-term growth. ** L&T:** AI infrastructure expansion enhances exposure to one of the fastest-growing technology segments globally. **Bharat Forge:** Continued beneficiary of defence manufacturing and export growth themes. **Overall View:** The announcements are broadly positive, particularly for Sun Pharma and L&T, as both companies continue to expand into high-growth strategic areas.